OMIA:002294-9615 : Cerebellar degeneration-myositis complex, SLC25A12-related in Canis lupus familiaris (dog)
Links to MONDO diseases: No links.
Mendelian trait/disorder: yes
Considered a defect: yes
Key variant known: yes
Year key variant first reported: 2019
Cross-species summary: CDMC
Species-specific name: Cerebellar degeneration-myositis complex, inflammatory myopathy
History: Shelton et al. (2019): "This report is the first description of a SLC25A12 variant resulting in an inflammatory myopathy in any species and reveals a complex pattern of metabolomic changes associated with this variant."
Molecular basis: Shelton et al. (2019): "After filtering these protein-coding homozygous variants against a dog genetic variant database . . . only one was unique to the sequenced case; a leucine to proline mutation (chr36:g.16,219,219A>G; c.1046T>C; p.L349P) within the SLC25A12 gene." SLC25A12 encodes the solute carrier family 25 member 2, a mitochondrial electrogenic aspartate/glutamate antiporter that favors efflux of aspartate and entry of glutamate and proton within the mitochondria as part of the malate-aspartate shuttle. Shelton et al. (2019) demonstrated that recombinant mutant SLC25A12 showed a strong impairment of transport activity compared to the wildtype protein. "As a result of this impaired transport, mitochondrial redox becomes more oxidizing with fewer reducing equivalents imported into the mitochondria via NADH. MAS defects lead to progressive intramitochondrial oxidation as NADH/NAD+ and NADPH/NADP+ ratios fall. The fall in intramitochondrial NADH/NAD+ ratio results in a highly oxidizing and proinflammatory muscle milieu. This is in contrast to the primary disorders of oxidative phosphorylation like complex I and complex IV deficiency leading to Leigh Syndrome, in which the mitochondria cannot consume the NADH that comes in and the intramitochondrial NADH/NAD+ ratio rises." (Shelton et al. 2019)
Christen et al. (2022) studied two litters of Nova Scotia Duck Tolling Retrievers, in which a total of four puppies were affected by a phenotype designated as cerebellar degeneration-myositis complex (CDMC). Whole genome sequencing of an affected dog at 29.1x coverage and comparison to 565 control genomes revealed 6 homozygous and 88 heterozygous private protein-changing variants. The authors identified a homozygous missense variant in SLC25A12 as the most likely candidate for the observed neurologic/neuromuscular phenotype. The identified variant was Chr36:16,504,064G>A (UU_Cfam_GSD_1.0 assembly) or XM_038584842.1:c.1337C>T or XP_038440770.1:(p.Pro446Leu). Genotypes at this variant showed the expected co-segregation with the phenotype in the available families and were perfectly associated with the disease phenotype in independently collected cohorts of 380 European and 153 North American Nova Scotia Duck Tolling Retrievers. The mutant allele frequencies in the European and North American cohorts were 3.6% abd 1.3%, respectively.
Have human generated variants been created, e.g. through genetic engineering and gene editing
Clinical features: Shelton et al. (2019) reported in Dutch Shepherd dogs with the p.L349P variant: "Five related Dutch Shepherd dogs with progressive muscle weakness and generalized muscle atrophy beginning at 3 to 9 months of age were euthanized by 2 years of age. Clinical signs included muscle tremors, pelvic limb stiffness, weakness progressing to inability to walk, and severe muscle atrophy. Serum CK activity was moderately elevated (ranging from 800–2,500 IU/L (reference values <200 IU/L) in all affected dogs, indicating myofiber damage. As far as could be determined, affected dogs did not have behavioral abnormalities or seizure activity, interacted with littermates and other dogs, and were visual with no ocular abnormalities noted. As myopathic changes predominated, extensive evaluations by a veterinary neurologist for central nervous system disease or by an ophthalmologist for ocular disease were not performed."
Christen et al. (2022) reported in 4 Nova Scotia Duck Tolling Retrievers with the p.P446L variant: "Age of onset of neurological signs was between 10 weeks and 6 months. Clinical abnormalities were restricted to the neuromuscular system in all four dogs. Neurological examination showed generalized ataxia and hypermetria, which was more pronounced in the pelvic limbs in all four dogs. Intentional head tremor was present in one dog. In two dogs, generalized neuromuscular weakness became apparent after 1 month, characterized by exercise intolerance, episodic collapse, stiff gait, and bunny hopping. Hopping was delayed in four limbs in three dogs, menace responses were absent in one dog, and decreased withdrawal reflexes were found in four limbs of three dogs." ... "Blood examination showed increases in serum creatine kinase concentrations in all four dogs (between 3 and 25 times greater than the upper reference limit). An EMG showed mild spontaneous activity in peripheral limb muscles. MRI of the brain in the same dog showed bilateral symmetrical lesions in the cerebellum and multifocal lesions in the masticatory muscles."
Shelton et al. (2019): "Histopathology of muscle biopsies confirmed an inflammatory myopathy and immune-mediated, infectious and dystrophic disorders were considered." Christen et al. (2022): "Muscle and nerve biopsies showed a fiber-invasive lymphohistiocytic myositis without evidence of intracellular infectious agents on histology and tissue PCR. The only other abnormality seen on postmortem examination was severe cerebellar nuclear degeneration. Based on the available clinical and diagnostic findings, we tentatively termed the phenotype of the four affected dogs cerebellar degeneration—myositis complex (CDMC)."
Christen et al. (2022): "Muscle and nerve biopsies showed a fiber-invasive lymphohistiocytic myositis without evidence of intracellular infectious agents on histology and tissue PCR. The only other abnormality seen on postmortem examination was severe cerebellar nuclear degeneration. Based on the available clinical and diagnostic findings, we tentatively termed the phenotype of the four affected dogs cerebellar degeneration—myositis complex (CDMC)."
Dutch Shepherd dog,
Nova Scotia Duck Tolling retriever.
Breeds in which the phene has been documented. For breeds in which a likely causal variant has been documented, see the variant table below
|Symbol||Description||Species||Chr||Location||OMIA gene details page||Other Links|
|SLC25A12||solute carrier family 25 (aspartate/glutamate carrier), member 12||Canis lupus familiaris||36||NC_051840.1 (16511922..16305983)||SLC25A12||Homologene, Ensembl , NCBI gene|
By default, variants are sorted chronologically by year of publication, to provide a historical perspective.
Readers can re-sort on any column by clicking on the column header. Click it again to sort in a descending
order. To create a multiple-field sort, hold down Shift while clicking on the second, third etc relevant column
WARNING! Inclusion of a variant in this table does not automatically mean that it should be used for DNA testing. Anyone contemplating the use of any of these variants for DNA testing should examine critically the relevant evidence (especially in breeds other than the breed in which the variant was first described). If it is decided to proceed, the location and orientation of the variant sequence should be checked very carefully.
Since October 2021, OMIA includes a semiautomated lift-over pipeline to facilitate updates of genomic positions to a recent reference genome position. These changes to genomic positions are not always reflected in the ‘acknowledgements’ or ‘verbal description’ fields in this table.
|OMIA Variant ID||Breed(s)||Variant Phenotype||Gene||Allele||Type of Variant||Source of Genetic Variant||Reference Sequence||Chr.||g. or m.||c. or n.||p.||Verbal Description||EVA ID||Inferred EVA rsID||Year Published||PubMed ID(s)||Acknowledgements|
|1262||Dutch Shepherd dog||Inflammatory myopathy, SLC25A12-related||SLC25A12||missense||Naturally occurring variant||CanFam3.1||36||g.16219219A>G||c.1046T>C||p.(L349P)||chr36:g.16,219,219A>G; c.1046T>C; p.L349P (Shelton et al., 2019)||2019||31594244|
|1471||Nova Scotia Duck Tolling retriever||Cerebellar Degeneration-Myositis Complex||SLC25A12||missense||Naturally occurring variant||UU_Cfam_GSD_1.0||36||g.16504064G>A||c.1337C>T||p.(P446L)||XM_038584842.1:c.1337C>T; XP_038440770.1:p.(P446L)||2022||35886006|
Cite this entry
Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.
|2023||Stee, K., Van Poucke, M., Lowrie, M., Van Ham, L., Peelman, L., Olby, N., Bhatti, S.F.M. :|
|Phenotypic and genetic aspects of hereditary ataxia in dogs. J Vet Intern Med 37:1306-1322, 2023. Pubmed reference: 37341581. DOI: 10.1111/jvim.16742.|
|2022||Christen, M., Rupp, S., Van Soens, I., Bhatti, S.F.M., Matiasek, K., von Klopmann, T., Jagannathan, V., Madden, I., Batcher, K., Bannasch, D., Leeb, T. :|
|SLC25A12 missense variant in Nova Scotia Duck Tolling Retrievers affected by cerebellar degeneration-myositis complex (CDMC). Genes (Basel) 13:1223, 2022. Pubmed reference: 35886006. DOI: 10.3390/genes13071223.|
|2019||Shelton, G.D., Minor, K.M., Li, K., Naviaux, J.C., Monk, J., Wang, L., Guzik, E., Guo, L.T., Porcelli, V., Gorgoglione, R., Lasorsa, F.M., Leegwater, P.J., Persico, A.M., Mickelson, J.R., Palmieri, L., Naviaux, R.K. :|
|A mutation in the mitochondrial aspartate/glutamate carrier leads to a more oxidizing intramitochondrial environment and an inflammatory myopathy in Dutch shepherd dogs. J Neuromuscul Dis 6:485-501, 2019. Pubmed reference: 31594244. DOI: 10.3233/JND-190421.|
- Created by Frank Nicholas on 30 Oct 2020
- Changed by Frank Nicholas on 30 Oct 2020
- Changed by Frank Nicholas on 04 Aug 2022
- Changed by Tosso Leeb on 04 Aug 2022